SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

                Date of Report (Date of earliest event reported):
                                 April 29, 2005


                          BIOACCELERATE HOLDINGS, INC.
               (Exact name of issuer as specified in its charter)


                                     NEVADA
                 (State or other jurisdiction of incorporation)


                        Commission file number: 333-43126
                            (Commission File Number)


                                   87-0650219
                        (IRS Employer Identification No.)


             19th Floor, 712 Fifth Avenue, New York, NY, 10019-4108
               (Address of principal executive offices) (Zip Code)


       Registrant's telephone number, including area code: (212) 897-6849


                                       N/A
          (Former name or former address, if changed since last report)
<PAGE>

ITEM 4.01 CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANTS

As of April 29, 2005,  the  Registrant  has appointed  new auditors.  Registrant
terminated F E Hanson Limited as the company's auditor.

Registrant  provided F E Hanson Limited,  the former accountant,  with a copy of
the  disclosures  it is making herein prior to the filing of this Current Report
on Form 8-K with the  Securities and Exchange  Commission  ("SEC") and requested
that F E Hanson  Limited  furnish the  Registrant a letter  addressed to the SEC
stating  if F E Hanson  Limited  does not agree  with the  representations  made
within this report 8-K.  The  decision to change  auditors  was  approved by the
Board of Directors.  The former  accountant  only acted for the Registrant  from
November 2004.  The prior  accountant did not render any report on the financial
statements  for the past two  years  which  contained  any  adverse  opinion  or
disclaimer  of opinion,  or was qualified or modified as to  uncertainty,  audit
scope or accounting  principles.  During the Registrant's two most recent fiscal
years and any subsequent  interim period preceding the termination there were no
disagreements with the former accountant on any matter of accounting  principles
or practices, financial statement disclosure, or auditing scope or procedure.

Simultaneously  with  the  termination  of  its  relationship  with  F E  Hanson
Limited.,   Registrant  retained  Stark,  Winter,  Schenkein,  &  Co.,  LLP,  as
registrant's independent auditors.  Stark, Winter, Schenkein, & Co LLP's address
is 7535 East Hampden Avenue, Suite 109, Denver, CO, 80231

The Registrant's Board of Directors  approved the appointment of Stark,  Winter,
Schenkein,  & Co LLP as the  Registrant's  independent  accountants on April 29,
2005.

During the most recent fiscal year and subsequent interim period, Registrant has
not consulted with Stark, Winter,  Schenkein,  & Co LLP regarding (i) either the
application  of  accounting  principles  to  a  specified  transaction,   either
completed  or proposed,  or the type of audit  opinion that might be rendered on
its  financial  statements,  or (ii) any matter  that was either the  subject of
disagreement  on any matter of accounting  principles  or  practices,  financial
statement  disclosure or auditing scope or procedures or a reportable  event (as
defined in Item 304(a)(1)(v) of Regulation S-K).

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(c)   Exhibits.

16.2. Registrants letter to Accountants dated April 28, 2005

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  Report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                             BIOACCELERATE HOLDINGS, INC.,
                                             A Nevada corporation (Registrant)


DATE: April 29, 2005                         BY: /S/ Linden Boyne
                                                --------------------------------
                                                Chief Financial Officer
<PAGE>

                                  Exhibit Index

16.2  Registrants letter to Accountants dated April 28, 2005
{"company-data": {"conformed-name": "BIOACCELERATE HOLDINGS INC", "cik": "0001119700", "assigned-sic": "1531", "irs-number": "870504461", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-43126", "film-number": "05798053"}, "business-address": {"street1": "712 FIFTH AVENUE", "street2": "19TH FLOOR", "city": "NEW YORK", "state": "NY", "zip": "10019", "phone": "(212) 897-6849"}, "mail-address": {"street1": "712 FIFTH AVENUE", "street2": "19TH FLOOR", "city": "NEW YORK", "state": "NY", "zip": "10019"}, "former-company": {"former-conformed-name": "MOBILE DESIGN CONCEPTS", "date-changed": "20000718"}}
SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

                Date of Report (Date of earliest event reported):
                                 April 29, 2005

                          BIOACCELERATE HOLDINGS, INC.
               (Exact name of issuer as specified in its charter)

                                     NEVADA
                 (State or other jurisdiction of incorporation)

                        Commission file number: 333-43126
                            (Commission File Number)

                                   87-0650219
                        (IRS Employer Identification No.)

             19th Floor, 712 Fifth Avenue, New York, NY, 10019-4108
               (Address of principal executive offices) (Zip Code)

       Registrant's telephone number, including area code: (212) 897-6849

                                       N/A
          (Former name or former address, if changed since last report)
ITEM 4.01 CHANGES IN REGISTRANT'S CERTIFYING ACCOUNTANTS

As of April 29, 2005,  the  Registrant  has appointed  new auditors.  Registrant
terminated F E Hanson Limited as the company's auditor.

Registrant  provided F E Hanson Limited,  the former accountant,  with a copy of
the  disclosures  it is making herein prior to the filing of this Current Report
on Form 8-K with the  Securities and Exchange  Commission  ("SEC") and requested
that F E Hanson  Limited  furnish the  Registrant a letter  addressed to the SEC
stating  if F E Hanson  Limited  does not agree  with the  representations  made
within this report 8-K.  The  decision to change  auditors  was  approved by the
Board of Directors.  The former  accountant  only acted for the Registrant  from
November 2004.  The prior  accountant did not render any report on the financial
statements  for the past two  years  which  contained  any  adverse  opinion  or
disclaimer  of opinion,  or was qualified or modified as to  uncertainty,  audit
scope or accounting  principles.  During the Registrant's two most recent fiscal
years and any subsequent  interim period preceding the termination there were no
disagreements with the former accountant on any matter of accounting  principles
or practices, financial statement disclosure, or auditing scope or procedure.

Simultaneously  with  the  termination  of  its  relationship  with  F E  Hanson
Limited.,   Registrant  retained  Stark,  Winter,  Schenkein,  &  Co.,  LLP,  as
registrant's independent auditors.  Stark, Winter, Schenkein, & Co LLP's address
is 7535 East Hampden Avenue, Suite 109, Denver, CO, 80231

The Registrant's Board of Directors  approved the appointment of Stark,  Winter,
Schenkein,  & Co LLP as the  Registrant's  independent  accountants on April 29,
2005.

During the most recent fiscal year and subsequent interim period, Registrant has
not consulted with Stark, Winter,  Schenkein,  & Co LLP regarding (i) either the
application  of  accounting  principles  to  a  specified  transaction,   either
completed  or proposed,  or the type of audit  opinion that might be rendered on
its  financial  statements,  or (ii) any matter  that was either the  subject of
disagreement  on any matter of accounting  principles  or  practices,  financial
statement  disclosure or auditing scope or procedures or a reportable  event (as
defined in Item 304(a)(1)(v) of Regulation S-K).

ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS

(c)   Exhibits.

16.2. Registrants letter to Accountants dated April 28, 2005

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  Report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                             BIOACCELERATE HOLDINGS, INC.,
                                             A Nevada corporation (Registrant)

DATE: April 29, 2005                         BY: /S/ Linden Boyne
                                                --------------------------------
                                                Chief Financial Officer
Exhibit Index

16.2  Registrants letter to Accountants dated April 28, 2005